the Prognosis of Fetoscopy Treatment of Twin Transfusion Syndrome
1 other identifier
observational
100
1 country
1
Brief Summary
Fetal medicine in China is still a new, young discipline, and the development is very rapid. After nearly 10 years of development, the clinical diagnosis and treatment guidelines of some complicated twin diseases has been established. Among them, twin-to-twin-transfusion syndrome (TTTS) is serious disease in twin pregnancy, and the factors affecting prognosis after fetoscopic laser surgery are part of the study. Through this study, the investigators expect to achieve better prediction indicators of the prognosis of TTTS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2021
CompletedStudy Start
First participant enrolled
July 1, 2021
CompletedFirst Posted
Study publicly available on registry
July 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedJuly 7, 2021
June 1, 2021
1 year
June 27, 2021
June 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weight in kilogram of neonate
Including twin pregnancy of TTTS after fetoscopic laser surgery measured by nurses
At birth of neonate
Secondary Outcomes (1)
Neurodevelopment at early childhood
At age of 1 year old
Eligibility Criteria
TTTS after fetoscopic laser surgery.
You may qualify if:
- TTTS after fetoscopic laser surgery.
You may not qualify if:
- Pregnant women who refuse to take part in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shengjing Hospital
Shenyang, Liaoning, 110004, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the second obstetrical department
Study Record Dates
First Submitted
June 27, 2021
First Posted
July 7, 2021
Study Start
July 1, 2021
Primary Completion
July 1, 2022
Study Completion (Estimated)
July 1, 2026
Last Updated
July 7, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share